CPT code 93897 designates an add-on emboli detection study performed alongside a complete Doppler ultrasound of the intracranial arteries to detect unattached clots or masses within the cerebral circulation. As an add-on service, it augments standard intracranial vascular imaging by providing focused monitoring for embolic signals that can influence acute stroke evaluation, secondary prevention planning, and referral decisions for further diagnostic workup. Nationally, this code matters for hospitals and outpatient vascular labs that manage cerebrovascular disease because it documents an advanced diagnostic step and can affect clinical pathways and resource use.

Key payers considered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, expected sites of service, common modifiers, and payer coverage considerations. The publication reviews benchmarks and utilization patterns where available, summarizes relevant policy and coding guidance, and situates the service within the clinical workflow for stroke and transient ischemic attack assessment. Data not provided in the input (such as specific utilization volumes, allowed amounts, and payer-specific coverage rules) are noted as unavailable.